Latest botox Stories

An Australian man says Botox injections enabled him to walk again 20 years after he was paralyzed with a stroke. My life has started all over again, said Russell McPhee. I have seen people cry when they realize I'm standing beside my chair. Tough men, blokes I went to school with and played sport with, weep when they see me. McPhee, 49, lost the ability to walk when he suffered a stroke at age 26, The Daily Telegraph reported Friday. After being treated with botox, however, McPhee was able...

A treatment some people use to ward away signs of aging could relieve chronic foot pain for people with diabetes. Taiwanese doctors have shown that pain, caused by nerve damage, can be reduced substantially by injections of botulinum toxin type A, better known as Botox. Dr. Chaur-Jong Hu, at Taipei Medical University, and his team of researchers tested the treatment in 18 patients with type 2 diabetes who had nerve-related pain in both feet.Study participants were randomly assigned by...

NORTH DALLAS, Texas and PLANO, Texas, April 30 /PRNewswire/ -- The battle for beauty now goes wrinkle-to-wrinkle, as Botox's rival, Dysport(TM), has received FDA clearance and is expected to begin their challenge to Botox(R) sometime within the next sixty days. The arrival of Dysport(TM) into the U.S. aesthetics market is sure to spark heated competition not only between the two wrinkle treatments, but also between medical professionals soon to be promoting one over the other, and as...

U.S. regulators warned consumers and doctors on Thursday about potentially deadly complications that can arise from off-label use of Allergan Inc.'s Botox and similar drugs.The U.S. Food and Drug Administration (FDA) said the wrinkle-smoother Botox and two other injections carry risks of rare botulism symptoms, especially when given to children to treat muscle spasms.Botulinum toxin can paralyze or relax muscles.  Although the drug is perhaps best known for its use as a wrinkle smoother,...

DENVER, April 27 /PRNewswire-USNewswire/ -- Phase II data presented at the annual meeting of the American Urology Association (AUA) indicate that men suffering from an enlarged prostate may benefit from BOTOX(R) injections. The two-stage, multi-center, double-blind, randomized study showed that two different dose levels of Botulinium Neurotoxin Type A (BOTOX) injected into the prostate was both safe and efficacious for the management of benign prostatic hyperplasia (BPH), a common...

15% of botox patients are now over 60 - Plastic Surgery increased too, with breast implants and facelifts increasing by a third - Longer lives, bigger bank balances and stunning senior celebs are influencing factors. MANCHESTER, England, April 25 /PRNewswire/ -- A NEW trend in beauty has been seen by staff at Transform, the UK's leading plastic surgeons and non-surgical treatments: the rise of Botox Grannies. More and more women over 60 are having non-surgical treatments including Botox,...

New Patient Video Vignettes and Mechanism of Action 3-D Video Illustrate the Versatility and Application of BOTOX(R) Across Several Approved Indications IRVINE, Calif., April 15 /PRNewswire-FirstCall/ -- As part of the nearly 20-year milestone since the first approved indications by the U.S. Food and Drug Administration (FDA) for BOTOX(R) (Botulinum Toxin Type A), Allergan, Inc. (NYSE: AGN), the maker of BOTOX(R) and BOTOX(R) Cosmetic, conducted a Web-based media briefing that provided an...

NORTH DALLAS, Texas and PLANO, Texas, April 13 /PRNewswire/ -- Botox's arch-nemesis, Reloxin(R), is expected to meet Botox(R) wrinkle-to-wrinkle in the U.S. cosmetics ring at any moment; whether U.S. injectors will readily embrace this new and slightly unfamiliar European cousin remains to be seen, but the incentive to, in the way of a significant potential cost savings, is certainly provocative. (Photo: http://www.newscom.com/cgi-bin/prnh/20090413/DA98188) In this corner: An aesthetics...

New Prescription Product Increases Length, Thickness and Darkness of Eyelashes IRVINE, Calif., Dec. 26 /PRNewswire-FirstCall/ -- Allergan, Inc. (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes. Eyelash hypotrichosis is another name for having inadequate or not enough eyelashes. LATISSE(TM) is the first and only science-based treatment approved by...

Keeping up one's looks appears to be trumping a weak economy, as U.S. doctors report the demand for Botox injections hasn't been pinched. Roughly three of four plastic surgeons who responded to an American Society of Plastic Surgeons survey reported demand for the minimally invasive wrinkle-erasing drug either remained steady or increased slightly, The Wall Street Journal reported Tuesday. However, the survey found the demand fell for more invasive and expensive cosmetic enhancements such as...